Global Radiosurgery and Radiotherapy Robotics Market 2017-2021

  • ID: 4143994
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
until May 31st 2018
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Accuray
  • Best Theratronics
  • Brainlab
  • Elekta
  • Huiheng Medical
  • Neusoft Medical Systems
  • MORE
About Radiosurgery and Radiotherapy Robotics

Radiosurgery is usually an oncologic treatment, which involves removing tumor cells through ionized radiation beams. As part of the surgery, a high dose of radiation beams is aimed at tumors from various orientations in a single sitting, while ensuring that the surrounding healthy tissues receive relatively less radiation. Radiotherapy, which is similar to radiosurgery, uses multiple fractionated doses of radiation to treat the tumor, thus requiring multiple sittings. Both these treatments are non-invasive, (i.e., they do not involve a cut or any contact with the body cavity or mucous membranes).

The analysts forecast the global radiosurgery and radiotherapy robotics market to grow at a CAGR of 6.48% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global radiosurgery and radiotherapy robotics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of these robots for market sizing for 2016-2021 while keeping 2016 as the base year.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Radiosurgery and Radiotherapy Robotics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Accuray
- Brainlab
- Elekta
- Varian Medical Systems

Other prominent vendors
- Best Theratronics
- Huiheng Medical
- MASEP Medical Science Technology Development
- Neusoft Medical Systems
- ViewRay
- Zhuhai Hokai Medical Instruments

Market drivers
- Developments in reimbursement procedures.
- For a full, detailed list, view the full report

Market challenges
- Competition from alternative treatments.
- For a full, detailed list, view the full report

Market trends
- Emergence of advanced radiotherapy treatments.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the Key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Accuray
  • Best Theratronics
  • Brainlab
  • Elekta
  • Huiheng Medical
  • Neusoft Medical Systems
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Healthcare robotics
  • Global radiosurgery and radiotherapy robotics market
  • Five forces analysis
PART 06: Market segmentation type of radiation beam used
  • Global radiosurgery and radiotherapy robotics market by type of radiation beam used
  • Global X-ray-based radiosurgery and radiotherapy robotics market
  • Global gamma-ray-based radiosurgery and radiotherapy robotics market
PART 07: Geographical segmentation
  • Global radiosurgery and radiotherapy robotics market by geography
  • Radiosurgery and radiotherapy robotics market in the Americas
  • Radiosurgery and radiotherapy robotics market in EMEA
  • Radiosurgery and radiotherapy robotics market in APAC
PART 08: Decision framework

PART 09: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 10: Market trends
  • Emergence of advanced radiotherapy treatments
  • Use for extracranial radiosurgery treatments
  • Improvement in customer support services by vendors
PART 11: Vendor landscape
  • Competitive scenario
  • Other prominent vendors
PART 12: Key vendor analysis
  • Accuray
  • Brainlab
  • Elekta
  • Varian Medical Systems
PART 13: Key takeaways

PART 14: Appendix
  • List of abbreviation
  • Glossary
List of Exhibits
Exhibit 01: Major cancer treatments
Exhibit 02: Categorization of robots in the healthcare sector
Exhibit 03: Drivers and challenges in healthcare robotics
Exhibit 04: Major innovations in medical robotics
Exhibit 05: Evolution of stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) over the years
Exhibit 06: Benefits of radiosurgery and radiotherapy robots
Exhibit 07: Steps in a radiosurgery
Exhibit 08: Major tumors and lesions treated using radiosurgery and radiotherapy
Exhibit 09: Global radiosurgery and radiotherapy robotics market 2016-2021 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Global radiosurgery and radiotherapy robotics market by type of radiation beam used 2016 and 2021
Exhibit 12: Features of X-ray-based radiosurgery and radiotherapy robots
Exhibit 13: Global X-ray-based radiosurgery and radiotherapy robotics market 2016-2021 ($ billions)
Exhibit 14: Features of gamma-ray-based radiosurgery and radiotherapy robots
Exhibit 15: Global gamma-ray-based radiosurgery and radiotherapy robotics market 2016-2021 ($ billions)
Exhibit 16: Distribution of gamma-ray-based-robots by type of tumor treated 2016 (%)
Exhibit 17: Global radiosurgery and radiotherapy robotics market by geography 2016 and 2021
Exhibit 18: Radiosurgery and radiotherapy robotics market in the Americas 2016-2021 ($ billions)
Exhibit 19: Radiosurgery and radiotherapy robotics market in EMEA 2016-2021 ($ billions)
Exhibit 20: Radiosurgery and radiotherapy robotics market in APAC 2016-2021 ($ billions)
Exhibit 21: Expected average cost of sensors 2015-2020 ($)
Exhibit 22: Impact of drivers
Exhibit 23: Comparison of conventional radiosurgery systems and non-invasive radiosurgery and radiotherapy robots
Exhibit 24: Possible side-effects of radiosurgery and radiotherapy
Exhibit 25: Cost comparison of major cancer treatments in the US
Exhibit 26: Alternative treatments available
Exhibit 27: Major regulations applicable to radiosurgery and radiotherapy robots
Exhibit 28: Impact of challenges
Exhibit 29: Emerging treatments in the field of oncology
Exhibit 30: Strategies for new entrants in the robotic surgery market
Exhibit 31: Other prominent vendors
Exhibit 32: Accuray: Product offerings
Exhibit 33: Recent developments: Accuray
Exhibit 34: Product offerings: Elekta
Exhibit 35: Recent developments: Elekta
Exhibit 36: Product offering: Varian Medical Systems
Exhibit 37: Recent developments: Varian Medical Systems
Exhibit 38: Glossary
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Accuray
  • Best Theratronics
  • Brainlab
  • Elekta
  • Huiheng Medical
  • Neusoft Medical Systems
  • MORE
New Report Released: – Global Radiosurgery and Radiotherapy Robotics Market 2017-2021

The author of the report recognizes the following companies as the key players in the global radiosurgery and radiotherapy robotics market: Accuray, Brainlab, Elekta, and Varian Medical Systems.

Other Prominent Vendors in the market are: Best Theratronics, Huiheng Medical, MASEP Medical Science Technology Development, Neusoft Medical Systems, ViewRay, and Zhuhai Hokai Medical Instruments.

Commenting on the report, an analyst from the research team said: “One trend in market is use for extracranial radiosurgery treatments. Extracranial radiosurgery is expected to gain traction during the forecast period as a new treatment option to treat tumors of the liver, lung, and spine, and other complicated cases. CyberKnife technology is especially useful in treating tumors with sub-millimeter precision. Other treatments require metal frames for tumors of brain, head, and neck, and body casts to limit movement during treatments of lung, liver, pancreas and kidney. Also, the treatment of prostate involves injection of hardening chemicals or rectal balloons. On the other hand, robotic systems like CyberKnife have the ability to conduct radiosurgeries without the requirement of any restricting frames, while ensuring greater accuracy in targeting a moving tumor.”

According to the report, one driver in market is increase in cancer cases and retreatments. A growing number of physicians and hospitals, which specialize in oncology treatments, are expected to adopt radiosurgery and radiotherapy for treatment of lesions and tumors. This is because these treatments enable a shorter treatment time and greater patient throughput, which ensures that the patient is immobilized on the treatment couch for a shorter period and allows patients to resume regular daily life soon. For physicians, it implies that there is a lesser probability of the tumor moving during the treatment, thus reducing throughput. This can eventually result in a higher number of patients being treated on a daily basis, hence greater revenue. Another major driver, especially for radiosurgery, is the rise in the cases of retreatment and relapse that makes radiosurgery a preferred choice as it involves a precise dose distribution, thus limiting the exposure of healthy tissues to excessive radiation.

Further, the report states that one challenge in market is high maintenance and equipment cost. Globally, end-users are gradually adopting robotic treatments in the healthcare sector. The adoption of robotic systems is better in developed countries of the Americas and Europe such as the US, Canada, the UK, Germany, Italy, Norway, Switzerland, France, and Sweden. Meanwhile, physicians in developing and emerging countries are still reluctant to choose radiosurgery and radiotherapy robots. Advances in medical robotic systems have increased the price of these devices, making treatments unaffordable for most patients in developing economies. For instance, gamma-ray-based radiosurgery and radiotherapy robots cost $4.5 million to $5.4 million and require additional maintenance and installation charges, which can go up to $2 million per annum. They also cause consumers to incur high capital and recurring costs, thus their accessibility is currently restricted to hospitals that are well-established or performs a large number of treatment procedures. Also, reimbursement rates vary and are not often significant when compared with laparoscopic procedures and other minimally invasive surgery (MIS) procedures. Thus, the high cost of these robots and the relatively less reimbursements provided to hospitals to invest on these robots will limit the demand for radiosurgery and radiotherapy robots in emerging markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Accuray
  • Brainlab
  • Elekta
  • Varian Medical Systems
  • Best Theratronics
  • Huiheng Medical
  • MASEP Medical Science Technology Development
  • Neusoft Medical Systems
  • ViewRay
  • Zhuhai Hokai Medical Instruments
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll